De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cabot Inkomsten in het verleden
Verleden criteriumcontroles 6/6
Cabot is de winst gegroeid met een gemiddeld jaarlijks percentage van 39.4%, terwijl de Chemicals industrie de winst jaarlijks groeide met 12.5%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 7.6% per jaar. Het rendement op eigen vermogen van Cabot is 35%, en het heeft een nettomarge van 11.9%.
Belangrijke informatie
39.4%
Groei van de winst
40.4%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 12.9% |
Inkomstengroei | 7.6% |
Rendement op eigen vermogen | 35.0% |
Nettomarge | 11.9% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet
Oct 07Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital
Sep 25Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Aug 19Cabot Corporation: Now A 'Hold' (Rating Downgrade)
Jul 31Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43
Jul 18Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns
Jun 23Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching
Jun 09Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43
May 24Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward
May 16Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit
May 13Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's
May 10Here's Why Cabot (NYSE:CBT) Has Caught The Eye Of Investors
May 07We Think Cabot (NYSE:CBT) Can Stay On Top Of Its Debt
Apr 09Cabot Corporation's (NYSE:CBT) CEO Will Probably Have Their Compensation Approved By Shareholders
Mar 01We Ran A Stock Scan For Earnings Growth And Cabot (NYSE:CBT) Passed With Ease
Jan 29Cabot Corp.: Dividend Trends By The Numbers
Jan 18Investors Don't See Light At End Of Cabot Corporation's (NYSE:CBT) Tunnel
Jan 16Returns At Cabot (NYSE:CBT) Appear To Be Weighed Down
Jan 03Cabot (NYSE:CBT) Has A Somewhat Strained Balance Sheet
Dec 20Cabot Corporation: Undervalued Given Margin Expansion Execution
Oct 27Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Oct 18Do Cabot's (NYSE:CBT) Earnings Warrant Your Attention?
Oct 05Cabot (NYSE:CBT) Has Some Way To Go To Become A Multi-Bagger
Sep 22Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.12?
Sep 03Cabot (NYSE:CBT) Seems To Use Debt Quite Sensibly
Aug 13Cabot: The Low Upside Potential Discourages Purchases
Aug 10Is Now The Time To Put Cabot (NYSE:CBT) On Your Watchlist?
Jun 18Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.68?
Jun 03Cabot Corporation Can Grow With America
May 25Cabot (NYSE:CBT) Is Increasing Its Dividend To $0.40
May 11Does Cabot (NYSE:CBT) Have A Healthy Balance Sheet?
Apr 06Does Cabot (NYSE:CBT) Deserve A Spot On Your Watchlist?
Mar 10Cabot (NYSE:CBT) Is Very Good At Capital Allocation
Feb 24Cabot (NYSE:CBT) Has Affirmed Its Dividend Of $0.37
Feb 11Cabot Non-GAAP EPS of $0.98 misses by $0.01, revenue of $965M beats by $9.76M
Feb 09Is Cabot Corporation (NYSE:CBT) Potentially Undervalued?
Feb 01Cabot (NYSE:CBT) Is Due To Pay A Dividend Of $0.37
Jan 19Cabot Corporation: Continued Upside Exists, I Say 'Buy'
Jan 19Is Cabot (NYSE:CBT) A Risky Investment?
Dec 26Cabot (NYSE:CBT) Is Paying Out A Dividend Of $0.37
Nov 14An Intrinsic Calculation For Cabot Corporation (NYSE:CBT) Suggests It's 37% Undervalued
Nov 05Cabot Usually Rises On Q4 Earnings - Potential 40% Upside
Nov 04Opbrengsten en kosten
Hoe Cabot geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 3,958 | 470 | 279 | 60 |
31 Mar 24 | 3,910 | 443 | 268 | 59 |
31 Dec 23 | 3,924 | 433 | 260 | 59 |
30 Sep 23 | 3,931 | 437 | 253 | 57 |
30 Jun 23 | 4,078 | 300 | 242 | 57 |
31 Mar 23 | 4,259 | 315 | 237 | 58 |
31 Dec 22 | 4,318 | 348 | 246 | 55 |
30 Sep 22 | 4,321 | 206 | 257 | 55 |
30 Jun 22 | 4,113 | 142 | 290 | 56 |
31 Mar 22 | 3,881 | 130 | 306 | 56 |
31 Dec 21 | 3,631 | 98 | 297 | 55 |
30 Sep 21 | 3,409 | 247 | 293 | 56 |
30 Jun 21 | 3,164 | -54 | 315 | 57 |
31 Mar 21 | 2,765 | -144 | 296 | 54 |
31 Dec 20 | 2,633 | -219 | 292 | 57 |
30 Sep 20 | 2,614 | -238 | 295 | 57 |
30 Jun 20 | 2,782 | 65 | 246 | 54 |
31 Mar 20 | 3,109 | 103 | 261 | 57 |
31 Dec 19 | 3,243 | 127 | 268 | 58 |
30 Sep 19 | 3,337 | 155 | 270 | 60 |
30 Jun 19 | 3,360 | 217 | 281 | 65 |
31 Mar 19 | 3,369 | 273 | 282 | 66 |
31 Dec 18 | 3,343 | 77 | 295 | 67 |
30 Sep 18 | 3,242 | -114 | 295 | 66 |
30 Jun 18 | 3,115 | -136 | 282 | 64 |
31 Mar 18 | 2,966 | -177 | 279 | 61 |
31 Dec 17 | 2,826 | 69 | 263 | 59 |
30 Sep 17 | 2,717 | 246 | 258 | 57 |
30 Jun 17 | 2,613 | 225 | 270 | 53 |
31 Mar 17 | 2,529 | 234 | 269 | 51 |
31 Dec 16 | 2,419 | 209 | 264 | 49 |
30 Sep 16 | 2,411 | 145 | 266 | 48 |
30 Jun 16 | 2,463 | 136 | 251 | 49 |
31 Mar 16 | 2,536 | -366 | 256 | 52 |
31 Dec 15 | 2,662 | -388 | 263 | 54 |
30 Sep 15 | 2,871 | -336 | 271 | 58 |
30 Jun 15 | 3,111 | -348 | 281 | 58 |
31 Mar 15 | 3,357 | 150 | 290 | 58 |
31 Dec 14 | 3,561 | 160 | 303 | 60 |
30 Sep 14 | 3,647 | 195 | 309 | 60 |
30 Jun 14 | 3,632 | 214 | 304 | 65 |
31 Mar 14 | 3,593 | 219 | 300 | 66 |
31 Dec 13 | 3,534 | 212 | 296 | 65 |
Kwaliteitswinsten: CBT heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (11.9%) CBT } zijn hoger dan vorig jaar (7.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van CBT is de afgelopen 5 jaar aanzienlijk gegroeid met 39.4% per jaar.
Versnelling van de groei: De winstgroei van CBT over het afgelopen jaar ( 56.7% ) overtreft het 5-jarig gemiddelde ( 39.4% per jaar).
Winst versus industrie: De winstgroei CBT over het afgelopen jaar ( 56.7% ) overtrof de Chemicals -sector -4.8%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 35% ) van CBT wordt als hoog beschouwd.